Machine learning reveals chronic graft-<i>versus</i>-host disease phenotypes and stratifies survival after stem cell transplant for hematologic malignancies
Jocelyn S. Gandelman(Vanderbilt University), Madan Jagasia(Vanderbilt University Medical Center), Kirsten E. Diggins(Vanderbilt University), Corey Cutler(Harvard University), Stephanie J. Lee(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Michael Byrne(Vanderbilt University Medical Center), Jonathan M. Irish(Vanderbilt University), Mukta Arora(Fairview Health Services), Akshitkumar M. Mistry(University of Louisville), Heidi Chen(Vanderbilt University Medical Center), Hannah G. Polikowsky(Vanderbilt University Medical Center), Joseph Pidala(Moffitt Cancer Center), Mary E.D. Flowers(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa)
Cited by 58
Related Papers
National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2014 Diagnosis and Staging Working Group Report
|Biology of Blood and Marrow Transplantation|2014|5.4k
Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis
|Cancer Cell|2005|3k
American Society of Clinical Oncology Recommendations on Fertility Preservation in Cancer Patients
|Journal of Clinical Oncology|2006|2k
HLA-Haploidentical Bone Marrow Transplantation for Hematologic Malignancies Using Nonmyeloablative Conditioning and High-Dose, Posttransplantation Cyclophosphamide
|Biology of Blood and Marrow Transplantation|2008|1.9k